The potential reassessment of cannabinoids, particularly at the federal level, is generating considerable excitement within the industry. A shift away from Schedule I status, often regarded as outdated and hindering https://albieihch938861.sasugawiki.com/7578572/cannabinoid_rescheduling_a_growth_catalyst